248 related articles for article (PubMed ID: 28748888)
1. Childhood idiopathic steroid-resistant nephrotic syndrome at a Single Center in Khartoum.
Ali EMA; Makki HFK; Abdelraheem MB; Makke SO; Allidir RA
Saudi J Kidney Dis Transpl; 2017; 28(4):851-859. PubMed ID: 28748888
[TBL] [Abstract][Full Text] [Related]
2. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
Olowu WA; Adelusola KA; Adefehinti O
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):979-90. PubMed ID: 20814150
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
Ladapo TA; Esezobor CI; Lesi FE
Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
[TBL] [Abstract][Full Text] [Related]
4. Childhood Idiopathic Steroid Resistant Nephrotic Syndrome, Different Drugs And Outcome.
Hussain Shah SS; Hafeez F
J Ayub Med Coll Abbottabad; 2016; 28(2):249-253. PubMed ID: 28718558
[TBL] [Abstract][Full Text] [Related]
5. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J; Ehrich JH; Querfeld U
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
11. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
[TBL] [Abstract][Full Text] [Related]
12. [Idiopathic steroid-resistant nephrotic syndrome in child : study of 20 cases].
Chemli J; Boussetta S; Krid S; Kahloul N; Hassayoun S; Zakhama A; Abroug S; Hachicha M; Amri F; Guediche MN; Sfar MT; Essoussi AS; Harbi A
Tunis Med; 2011 Jun; 89(6):522-8. PubMed ID: 21681713
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P; Panczyk-Tomaszewska M; Roszkowska-Blaim M; Wawer Z; Bienias B; Zajgzkowska M; Kilis-Pstrusinska K; Jakubowska A; Szczepaniak M; Pawlak-Bratkowska M; Tkaczyk M
Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
[TBL] [Abstract][Full Text] [Related]
14. Steroid resistant nephrotic syndrome: role of histopathology.
Gulati S; Sengupta D; Sharma RK; Sharma A; Gupta RK; Singh U; Gupta A
Indian Pediatr; 2006 Jan; 43(1):55-60. PubMed ID: 16465008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome.
Shah SS; Hafeez F
J Coll Physicians Surg Pak; 2016 Jul; 26(7):589-93. PubMed ID: 27504551
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
17. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
18. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
El-Reshaid K; El-Reshaid W; Madda J
Ren Fail; 2005; 27(5):523-30. PubMed ID: 16152989
[TBL] [Abstract][Full Text] [Related]
19. Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome.
Shenoy M; Plant ND; Lewis MA; Bradbury MG; Lennon R; Webb NJ
Pediatr Nephrol; 2010 May; 25(5):899-903. PubMed ID: 20108003
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
